Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931920 | 0.88 | ALDH1A1 (0.60) | ALDH1A1TDP1CYP3A4TSHRATM | |
| Urethane SCHEMBL6236113 | 0.86 | ALDH1A1 (0.62) | ALDH1A1TDP1ALOX15CYP3A4TSHR | |
| Carbamic Acid SCHEMBL28700287 | 0.83 | ALDH1A1 (0.75) | ALDH1A1TDP1CYP3A4TSHRATM | |
| Bicarbonate SCHEMBL909943 | 0.81 | ALDH1A1 (0.78) | ALDH1A1TDP1CYP3A4TSHRATM | |
| SCHEMBL467542 | 0.80 | CYP3A4 (0.66) | ALDH1A1TDP1CYP3A4TSHRATM | |
| Acetic Acid SCHEMBL1878883 | 0.80 | ALDH1A1 (0.75) | ALDH1A1TDP1CYP3A4TSHRATM | |
| SCHEMBL27148576 | 0.79 | ALDH1A1 (0.62) | ALDH1A1TDP1CYP3A4TSHRATM | |
| SCHEMBL28690 | 0.79 | — | — | |
| SCHEMBL2599658 | 0.79 | — | — | |
| SCHEMBL9004577 | 0.79 | ALDH1A1 (1.00) | ALDH1A1TDP1ALOX15CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013298-B1 | COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME | INKTEC CO LTD (KR) | 2018-06-27 | — | — | EP | disclosed |
| US-8445578-B2 | Compositions for forming reflecting layer having organic silver complexes, and method for preparing reflecting layer using same | INKTEC CO., LTD. (KR) | 2013-05-21 | — | — | US | disclosed |
| US-20090220696-A1 | Compositions for Forming Reflecting Layer Having Organic Silver Complexes, and Method for Preparing Reflecting Layer Using Same | INKTEC CO., LTD. (KP) | 2009-09-03 | — | — | US | disclosed |
| EP-2013298-A1 | COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME | Inktec Co., Ltd. (KR) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007126276-A1 | COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME | INKTEC CO., LTD. (KR) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220696-A1 | Compositions for Forming Reflecting Layer Having Organic Silver Complexes, and Method for Preparing Reflecting Layer Using Same | EPCAM, FCGR3B, APOL1 | ALDH1A1 2180/4885TDP1 1655/4885ALOX15 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.